Robert Iannone MD MD, MSCE
Vice President Immuno-oncology AstraZeneca Global Medicines
Join to View Full Profile
3401 Civic Center BlvdChildren's Hospital Of Philadelphia - Hem/OncPhiladelphia, PA 19104
Phone+1 215-590-3535
Fax+1 215-590-3992
Dr. Iannone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1997 - 2001- Johns Hopkins UniversityResidency, Pediatrics, 1994 - 1997
Yale School of MedicineClass of 1994
Certifications & Licensure
PA State Medical License 2001 - 2026
MD State Medical License 1997 - 2002
Clinical Trials
- Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread Start of enrollment: 2018 Aug 13
Publications & Presentations
PubMed
- Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study.Luke Maese, Mignon L Loh, Mi Rim Choi, Shirali Agarwal, Etsuko Aoki
Blood Advances. 2025-01-14 - 13 citationsRecombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study.Luke Maese, Mignon L Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki
Blood. 2023-02-16 - 9 citationsA Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's ...Stella M. Davies, Robert Iannone, Todd A. Alonzo, Yi-Cheng Wang, Robert B. Gerbing
Biology of Blood and Marrow Transplantation. 2020-04-01
Press Mentions
- U.S. FDA Grants Orphan Drug Exclusivity (ODE) for Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution for Idiopathic Hypersomnia in AdultsJanuary 3rd, 2022
- Stand up to Cancer and Jazz Pharmaceuticals Collaborate to Fund Catalyst Research on Hard-to-Treat CancersAugust 11th, 2021
- Jazz Closes on GW Pharma, Reports ResultsMay 5th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
